GREGG ETTER: Open Payments
NPI 1962409649 · RIVERSIDE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 24 payments from 7 companies in 2025. Trend: 2023 $250 · 2024 $367 · 2025 $606
Food & beverage: $494Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $221 |
| E.R. Squibb & Sons, L.L.C. | 7 | $135 |
| Alkermes, Inc. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Lundbeck LLC | 1 | $14 |
Products named: COBENFY, UZEDY, ARISTADA, INGREZZA, CAPLYTA, REXULTI, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across RI — which companies pay providers there.
